{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:36:01Z","timestamp":1791408961003,"version":"4.3.3"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00281-013-0415-3","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T12:31:03Z","timestamp":1389184263000},"page":"421-429","source":"Crossref","is-referenced-by-count":48,"title":["Immunopathogenesis of idiopathic nephrotic syndrome with relapse"],"prefix":"10.1007","volume":"36","author":[{"given":"Djillali","family":"Sahali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelhia","family":"Sendeyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Mangier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ollero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"415_CR1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00008480-199304000-00007","volume":"5","author":"P Niaudet","year":"1993","unstructured":"Niaudet P (1993) Nephrotic syndrome in children. Curr Opin Pediatr 5:174\u2013179","journal-title":"Curr Opin Pediatr"},{"key":"415_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S (2002) Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis 39:503\u2013512","journal-title":"Am J Kidney Dis"},{"key":"415_CR3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00281-007-0094-z","volume":"29","author":"PW Mathieson","year":"2007","unstructured":"Mathieson PW (2007) Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol 29:415\u2013426","journal-title":"Semin Immunopathol"},{"key":"415_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestila","year":"1998","unstructured":"Kestila M, Lenkkeri U, Mannikko M et al (1998) Positionally cloned gene for a novel glomerular protein\u2014nephrin\u2014is mutated in congenital nephrotic syndrome. Mol Cell 1:575\u2013582","journal-title":"Mol Cell"},{"key":"415_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/74166","volume":"24","author":"N Boute","year":"2000","unstructured":"Boute N, Gribouval O, Roselli S et al (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349\u2013354","journal-title":"Nat Genet"},{"key":"415_CR6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/ng1918","volume":"38","author":"B Hinkes","year":"2006","unstructured":"Hinkes B, Wiggins RC, Gbadegesin R et al (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38:1397\u20131405","journal-title":"Nat Genet"},{"key":"415_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/73456","volume":"24","author":"JM Kaplan","year":"2000","unstructured":"Kaplan JM, Kim SH, North KN et al (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251\u2013256","journal-title":"Nat Genet"},{"key":"415_CR8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ng1592","volume":"37","author":"J Reiser","year":"2005","unstructured":"Reiser J, Polu KR, Moller CC et al (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739\u2013744","journal-title":"Nat Genet"},{"key":"415_CR9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.ki.5002469","volume":"72","author":"MM Lowik","year":"2007","unstructured":"Lowik MM, Groenen PJ, Pronk I et al (2007) Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int 72:1198\u20131203","journal-title":"Kidney Int"},{"key":"415_CR10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.505","volume":"42","author":"EJ Brown","year":"2010","unstructured":"Brown EJ, Schlondorff JS, Becker DJ et al (2010) Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet 42:72\u201376","journal-title":"Nat Genet"},{"key":"415_CR11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639","journal-title":"Lancet"},{"key":"415_CR12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V et al (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"415_CR13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","volume":"83","author":"H Munyentwali","year":"2013","unstructured":"Munyentwali H, Bouachi K, Audard V et al (2013) Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney Int 83:511\u2013516","journal-title":"Kidney Int"},{"key":"415_CR14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","volume":"84","author":"P Ravani","year":"2013","unstructured":"Ravani P, Ponticelli A, Siciliano C et al (2013) Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84:1025\u20131033","journal-title":"Kidney Int"},{"key":"415_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000313947","volume":"169","author":"S Zhang","year":"2011","unstructured":"Zhang S, Audard V, Fan Q et al (2011) Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol 169:94\u2013106","journal-title":"Contrib Nephrol"},{"key":"415_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","volume":"10","author":"HK Yap","year":"1999","unstructured":"Yap HK, Cheung W, Murugasu B et al (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529\u2013537","journal-title":"J Am Soc Nephrol"},{"key":"415_CR17","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK et al (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18:1476\u20131485","journal-title":"J Am Soc Nephrol"},{"key":"415_CR18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V113413","volume":"11","author":"JG Berg Van Den","year":"2000","unstructured":"Van Den Berg JG, Aten J, Chand MA et al (2000) Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol 11:413\u2013422","journal-title":"J Am Soc Nephrol"},{"key":"415_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BSR20110102","volume":"32","author":"P Zhu","year":"2012","unstructured":"Zhu P, Goh YY, Chin HF et al (2012) Angiopoietin-like 4: a decade of research. Bioscience reports 32:211\u2013219","journal-title":"Bioscience reports."},{"key":"415_CR20","doi-asserted-by":"crossref","unstructured":"Koliwad SK, Gray NE, Wang JC. Angiopoietin-like 4 (Angptl4) (2012): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting. Adipocyte.1:182\u2013187.","DOI":"10.4161\/adip.20787"},{"key":"415_CR21","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","volume":"284","author":"SK Koliwad","year":"2009","unstructured":"Koliwad SK, Kuo T, Shipp LE et al (2009) Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem 284:25593\u201325601","journal-title":"J Biol Chem"},{"key":"415_CR22","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","volume":"146","author":"A Koster","year":"2005","unstructured":"Koster A, Chao YB, Mosior M et al (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146:4943\u20134950","journal-title":"Endocrinology"},{"key":"415_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C et al (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117\u2013122","journal-title":"Nat Med"},{"key":"415_CR24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M et al (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113:1390\u20131397","journal-title":"J Clin Invest"},{"key":"415_CR25","doi-asserted-by":"crossref","unstructured":"Garin EH, Diaz LN, Mu W, Wasserfall C et al (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20: 260\u2013266.","DOI":"10.1681\/ASN.2007080836"},{"key":"415_CR26","doi-asserted-by":"crossref","unstructured":"Garin EH, MuW, Arthur JMet al (2010) Urinary CD80 is elevated in minimal change di sease but not in focal s egmental glomerulosclerosis. Kidney Int 78:296\u2013302","DOI":"10.1038\/ki.2010.143"},{"key":"415_CR27","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1093\/ndt\/gfr128","volume":"26","author":"M Navarro-Munoz","year":"2011","unstructured":"Navarro-Munoz M, Ibernon M, Perez V et al (2011) Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients. Nephrol Dial Transplant 26:3914\u20133923","journal-title":"Nephrol Dial Transplant"},{"key":"415_CR28","unstructured":"Yu CC, Fornoni A, Weins A et al (2013) Abatacept in B7-1-Positive Proteinuric Kidney Disease. N Engl J Med 2013"},{"key":"415_CR29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.V1351238","volume":"13","author":"D Sahali","year":"2002","unstructured":"Sahali D, Pawlak A, Valanciute A et al (2002) A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13:1238\u20131247","journal-title":"J Am Soc Nephrol"},{"key":"415_CR30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1084\/jem.20030566","volume":"198","author":"P Grimbert","year":"2003","unstructured":"Grimbert P, Valanciute A, Audard V et al (2003) Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 198:797\u2013807","journal-title":"J Exp Med"},{"key":"415_CR31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.molimm.2008.09.034","volume":"46","author":"M Kamal","year":"2009","unstructured":"Kamal M, Valanciute A, Dahan K et al (2009) C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity. Mol Immunol 46:991\u2013998","journal-title":"Mol Immunol"},{"key":"415_CR32","doi-asserted-by":"crossref","unstructured":"Zhang SY, Kamal M, Dahan K et al. (2010) c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal 3:ra39.","DOI":"10.1126\/scisignal.2000678"},{"key":"415_CR33","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","volume":"115","author":"V Audard","year":"2010","unstructured":"Audard V, Zhang SY, Copie-Bergman C et al (2010) Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes. Blood 115:3756\u20133762","journal-title":"Blood"},{"key":"415_CR34","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2215\/CJN.03770412","volume":"7","author":"JF Cambier","year":"2012","unstructured":"Cambier JF, Ronco P (2012) Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol 7:1701\u20131712","journal-title":"Clin J Am Soc Nephrol"},{"key":"415_CR35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2012.426","volume":"83","author":"K Sendeyo","year":"2013","unstructured":"Sendeyo K, Audard V, Zhang SY et al (2013) Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy. Kidney Int 83:414\u2013425","journal-title":"Kidney Int"},{"key":"415_CR36","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ajpath.2012.02.008","volume":"180","author":"V Ory","year":"2012","unstructured":"Ory V, Fan Q, Hamdaoui N et al (2012) c-mip down-regulates NF-kappaB activity and promotes apoptosis in podocytes. Am J Pathol 180:2284\u20132292","journal-title":"Am J Pathol"},{"key":"415_CR37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.molmed.2007.06.006","volume":"13","author":"J Patrakka","year":"2007","unstructured":"Patrakka J, Tryggvason K (2007) Nephrin\u2014a unique structural and signaling protein of the kidney filter. Trends Mol Med 13:396\u2013403","journal-title":"Trends Mol Med"},{"key":"415_CR38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1074\/jbc.M112.439463","volume":"288","author":"LA New","year":"2013","unstructured":"New LA, Keyvani Chahi A, Jones N (2013) Direct regulation of nephrin tyrosine phosphorylation by Nck adaptor proteins. J Biol Chem 288:1500\u20131510","journal-title":"J Biol Chem"},{"key":"415_CR39","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1128\/MCB.23.14.4917-4928.2003","volume":"23","author":"TB Huber","year":"2003","unstructured":"Huber TB, Hartleben B, Kim J et al (2003) Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23:4917\u20134928","journal-title":"Mol Cell Biol"},{"key":"415_CR40","doi-asserted-by":"crossref","first-page":"14110","DOI":"10.1073\/pnas.0602587103","volume":"103","author":"I Quack","year":"2006","unstructured":"Quack I, Rump LC, Gerke P et al (2006) beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity. Proc Natl Acad Sci U S A 103:14110\u201314115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"415_CR41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ki.2008.19","volume":"73","author":"K Uchida","year":"2008","unstructured":"Uchida K, Suzuki K, Iwamoto M et al (2008) Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 73:926\u2013932","journal-title":"Kidney Int"},{"key":"415_CR42","doi-asserted-by":"crossref","first-page":"F48","DOI":"10.1152\/ajprenal.00146.2004","volume":"288","author":"RR Foster","year":"2005","unstructured":"Foster RR, Saleem MA, Mathieson PW et al (2005) Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 288:F48\u2013F57","journal-title":"Am J Physiol Renal Physiol"},{"key":"415_CR43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI200112367","volume":"108","author":"M Schiffer","year":"2001","unstructured":"Schiffer M, Bitzer M, Roberts IS et al (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807\u2013816","journal-title":"J Clin Invest"},{"key":"415_CR44","doi-asserted-by":"crossref","first-page":"37004","DOI":"10.1074\/jbc.M403534200","volume":"279","author":"M Schiffer","year":"2004","unstructured":"Schiffer M, Mundel P, Shaw AS et al (2004) A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J Biol Chem 279:37004\u201337012","journal-title":"J Biol Chem"},{"key":"415_CR45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1126\/science.286.5438.312","volume":"286","author":"NYLJ Shih","year":"1999","unstructured":"Shih NYLJ, Karpitskii V, Nguyen A et al (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312\u2013315","journal-title":"Science"},{"key":"415_CR46","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ndt\/17.6.998","volume":"17","author":"N Sakai","year":"2002","unstructured":"Sakai N, Wada T, Furuichi K et al (2002) p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 17:998\u20131004","journal-title":"Nephrol Dial Transplant"},{"key":"415_CR47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.ASN.0000108520.63445.E0","volume":"15","author":"C Stambe","year":"2004","unstructured":"Stambe C, Nikolic-Paterson DJ, Hill PA et al (2004) p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol 15:326\u2013336","journal-title":"J Am Soc Nephrol"},{"key":"415_CR48","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1681\/ASN.2004121084","volume":"16","author":"M Koshikawa","year":"2005","unstructured":"Koshikawa M, Mukoyama M, Mori K et al (2005) Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16:2690\u20132701","journal-title":"J Am Soc Nephrol"},{"key":"415_CR49","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1096\/fj.11-202994","volume":"26","author":"A Mima","year":"2012","unstructured":"Mima A, Kitada M, Geraldes P et al (2012) Glomerular VEGF resistance induced by PKCdelta\/SHP-1 activation and contribution to diabetic nephropathy. FASEB J 26:2963\u20132974","journal-title":"FASEB J"},{"key":"415_CR50","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1002\/j.1460-2075.1995.tb00305.x","volume":"14","author":"Y Emoto","year":"1995","unstructured":"Emoto Y, Manome Y, Meinhardt G et al (1995) Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 14:6148\u20136156","journal-title":"EMBO J"},{"key":"415_CR51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.febslet.2009.12.015","volume":"584","author":"M Kamal","year":"2010","unstructured":"Kamal M, Pawlak BMAF et al (2010) C-mip interacts with the p85 subunit of PI3 kinase and exerts a dual effect on ERK signaling via the recruitment of Dip1 and DAP kinase. FEBS Lett 584:500\u2013506","journal-title":"FEBS Lett"},{"key":"415_CR52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1083\/jcb.200204050","volume":"159","author":"WJ Wang","year":"2002","unstructured":"Wang WJ, Kuo JC, Yao CC et al (2002) DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 159:169\u2013179","journal-title":"J Cell Biol"},{"key":"415_CR53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1083\/jcb.200310148","volume":"164","author":"CW Gourlay","year":"2004","unstructured":"Gourlay CW, Carpp LN, Timpson P et al (2004) A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 164:803\u2013809","journal-title":"J Cell Biol"},{"key":"415_CR54","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J et al (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129\u20131136","journal-title":"N Engl J Med"},{"key":"415_CR55","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2010030295","volume":"21","author":"K Sison","year":"2010","unstructured":"Sison K, Eremina V, Baelde H et al (2010) Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol 21:1691\u20131701","journal-title":"J Am Soc Nephrol"},{"key":"415_CR56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.2010.64","volume":"77","author":"D Veron","year":"2010","unstructured":"Veron D, Reidy KJ, Bertuccio C et al (2010) Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int 77:989\u2013999","journal-title":"Kidney Int"},{"key":"415_CR57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrclinonc.2009.130","volume":"6","author":"SP Ivy","year":"2009","unstructured":"Ivy SP, Wick JY, Kaufman BM (2009) An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 6:569\u2013579","journal-title":"Nat Rev Clin Oncol"},{"key":"415_CR58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","volume":"46","author":"H Izzedine","year":"2010","unstructured":"Izzedine H, Massard C, Spano JP et al (2010) VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management. Eur J Cancer 46:439\u2013448","journal-title":"Eur J Cancer"},{"key":"415_CR59","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuroscience.2009.05.019","volume":"162","author":"V Echeverria","year":"2009","unstructured":"Echeverria V, Burgess S, Gamble-George J et al (2009) Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience 162:1220\u20131231","journal-title":"Neuroscience"},{"key":"415_CR60","first-page":"43","volume":"28","author":"P Niaudet","year":"1998","unstructured":"Niaudet P, Gagnadoux MF, Broyer M (1998) Treatment of childhood steroid-resistant idiopathic nephrotic syndrome. Adv Nephrol Necker Hosp 28:43\u201361","journal-title":"Adv Nephrol Necker Hosp"},{"key":"415_CR61","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A et al (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117\u20131124","journal-title":"J Am Soc Nephrol"},{"key":"415_CR62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.V22109","volume":"2","author":"EL Ramos","year":"1991","unstructured":"Ramos EL (1991) Recurrent diseases in the renal allograft. J Am Soc Nephrol 2:109\u2013121","journal-title":"J Am Soc Nephrol"},{"key":"415_CR63","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MNH.0b013e32833d6904","volume":"19","author":"T Fairhead","year":"2010","unstructured":"Fairhead T, Knoll G (2010) Recurrent glomerular disease after kidney transplantation. Curr Opin Nephrol Hypertens 19:578\u2013585","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"415_CR64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trre.2010.04.001","volume":"24","author":"G Canaud","year":"2010","unstructured":"Canaud G, Martinez F, Noel LH et al (2010) Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev (Orlando) 24:121\u2013128","journal-title":"Transplant Rev (Orlando)"},{"key":"415_CR65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajt.12045","volume":"13","author":"P Cravedi","year":"2013","unstructured":"Cravedi P, Kopp JB, Remuzzi G (2013) Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant 13:266\u2013274","journal-title":"Am J Transplant"},{"key":"415_CR66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(72)91734-5","volume":"2","author":"JR Hoyer","year":"1972","unstructured":"Hoyer JR, Vernier RL, Najarian JS et al (1972) Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 2:343\u2013348","journal-title":"Lancet"},{"key":"415_CR67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1056\/NEJM200102013440517","volume":"344","author":"MJ Kemper","year":"2001","unstructured":"Kemper MJ, Wolf G, Muller-Wiefel DE (2001) Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 344:386\u2013387","journal-title":"N Engl J Med"},{"key":"415_CR68","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00007890-199410000-00018","volume":"58","author":"AA Ali","year":"1994","unstructured":"Ali AA, Wilson E, Moorhead JF et al (1994) Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 58:849\u2013852","journal-title":"Transplantation"},{"key":"415_CR69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ndt\/16.2.416","volume":"16","author":"R Rea","year":"2001","unstructured":"Rea R, Smith C, Sandhu K et al (2001) Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transplant 16:416\u2013417","journal-title":"Nephrol Dial Transplant"},{"key":"415_CR70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/ajkd.1998.v32.pm9708606","volume":"32","author":"SMFP Feld","year":"1998","unstructured":"Feld SMFP, Savin V, Nast CC (1998) Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 32:230\u2013237","journal-title":"Am J Kidney Dis"},{"key":"415_CR71","first-page":"282","volume":"48","author":"DSDP Ginsburg","year":"1997","unstructured":"Ginsburg DSDP (1997) Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis. Clin Nephrol 48:282\u2013287","journal-title":"Clin Nephrol"},{"key":"415_CR72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199401063300102","volume":"330","author":"J Dantal","year":"1994","unstructured":"Dantal J, Bigot E, Bogers W et al (1994) Effect of plasma protein adsorption on protein excretion in kidney- transplant recipients with recurrent nephrotic syndrome [see comments]. N Engl J Med 330:7\u201314","journal-title":"N Engl J Med"},{"key":"415_CR73","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1681\/ASN.V991709","volume":"9","author":"J Dantal","year":"1998","unstructured":"Dantal J, Godfrin Y, Koll R et al (1998) Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9:1709\u20131715","journal-title":"J Am Soc Nephrol"},{"key":"415_CR74","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","volume":"334","author":"VJ Savin","year":"1996","unstructured":"Savin VJ, Sharma R, Sharma M et al (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878\u2013883","journal-title":"N Engl J Med"},{"key":"415_CR75","first-page":"72","volume":"20","author":"JM Boulton Jones","year":"1983","unstructured":"Boulton Jones JM, Tulloch I, Dore B et al (1983) Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 20:72\u201377","journal-title":"Clin Nephrol"},{"key":"415_CR76","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000185325","volume":"51","author":"N Yoshizawa","year":"1989","unstructured":"Yoshizawa N, Kusumi Y, Matsumoto K et al (1989) Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron 51:370\u2013376","journal-title":"Nephron"},{"key":"415_CR77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","volume":"40","author":"A Koyama","year":"1991","unstructured":"Koyama A, Fujisaki M, Kobayashi M et al (1991) A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453\u2013460","journal-title":"Kidney Int"},{"key":"415_CR78","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"ET McCarthy","year":"2010","unstructured":"McCarthy ET, Sharma M, Savin VJ (2010) Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5:2115\u20132121","journal-title":"Clin J Am Soc Nephrol"},{"key":"415_CR79","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A et al (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952\u2013960","journal-title":"Nat Med"},{"key":"415_CR80","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","volume":"268","author":"J Eugen-Olsen","year":"2010","unstructured":"Eugen-Olsen J, Andersen O, Linneberg A et al (2010) Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 268:296\u2013308","journal-title":"J Intern Med"},{"key":"415_CR81","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","volume":"8","author":"ME Bock","year":"2013","unstructured":"Bock ME, Price HE, Gallon L, Langman CB (2013) Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 8:1304\u20131311","journal-title":"Clin J Am Soc Nephrol"},{"key":"415_CR82","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.2012.32","volume":"81","author":"RJ Maas","year":"2012","unstructured":"Maas RJ, Wetzels JF, Deegens JK (2012) Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int 81:1043\u20131044","journal-title":"Kidney Int"},{"key":"415_CR83","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","volume":"23","author":"C Wei","year":"2012","unstructured":"Wei C, Trachtman H, Li J et al (2012) Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23:2051\u20132059","journal-title":"J Am Soc Nephrol"},{"key":"415_CR84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","volume":"96","author":"CR Franco Palacios","year":"2013","unstructured":"Franco Palacios CR, Lieske JC, Wadei HM et al (2013) Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation 96:394\u2013399","journal-title":"Transplantation"},{"key":"415_CR85","doi-asserted-by":"crossref","unstructured":"Beaudreuil S, Zhang X, Kriaa F et al. (2013) Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis. Nephrol Dial Transplant. Nov 13 [Epub ahead of print].","DOI":"10.1093\/ndt\/gft453"},{"key":"415_CR86","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C et al (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46","journal-title":"Sci Transl Med"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-013-0415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-013-0415-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-013-0415-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T22:33:16Z","timestamp":1647901996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-013-0415-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s00281-013-0415-3","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}